phrykt

INSMED (INSM) cash: $510M

INSMED held $510M in cash and cash equivalents on Dec 31, 2025, down 8.0% from $555M a year earlier.

From INSMED's filings with the SEC · Read the filing · INSM stock page

INSMED cash by year

$717M2021$1.1B2022$482M2023$555M2024$510M2025

#871 of 4,171 US companies by cash · See the full ranking

Year endedCashChange
Dec 31, 2025$510M-8%
Dec 31, 2024$555M+15%
Dec 31, 2023$482M-55%
Dec 31, 2022$1.1B+50%
Dec 31, 2021$717M–

Cash of similar companies

Companies in the same industry as INSMED, by SEC industry code, with the closest cash. Each name opens the same page for that company.

CompanyCash, latest yearYear ended
Organon$574MDec 31, 2025
BridgeBio Pharma$570MDec 31, 2025
Innoviva$551MDec 31, 2025
Elanco Animal Health$545MDec 31, 2025
PERRIGO$532MDec 31, 2025
INSMED$510MDec 31, 2025
NewAmsterdam Pharma$490MDec 31, 2025

Questions and answers

What is INSMED's cash?

INSMED held $510M in cash and cash equivalents on Dec 31, 2025, down 8.0% from $555M a year earlier.

Numbers as reported in INSMED's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology